Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
Go back to Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting| (NASDAQ: EVAX) | Delayed: 3.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.71 | 52 Week High | $ | |||
| Open | $3.73 | 52 Week Low | $ | |||
| Day High | $3.75 | P/E | N/A | |||
| Day Low | $3.55 | EPS | $ | |||
| Volume | 107,790 | |||||



